Drug Spending
-
Vox: A CT scan costs $1,100 in the US — and $140 in Holland
Tags: Administered Drugs, Commercially Insured, Drug Spending, Inpatient Spending, Outpatient Spending, Prices, Vox
Read more: Vox: A CT scan costs $1,100 in the US — and $140 in HollandHCCI’s work with iFHP on international comparisons of health care price was featured in a Vox article. America’s health care costs problem, explained in 4 charts – Vox America’s health care prices problem, in four charts. https://www.vox.com/policy-and-politics/2019/12/17/21024614/us-health-care-costs-medical-prices
-
International comparisons of health care prices from the 2017 iFHP survey
Tags: Administered Drugs, Commercially Insured, Drug Spending, Inpatient Spending, Outpatient Spending, PricesRead more: International comparisons of health care prices from the 2017 iFHP surveyThe International Federation of Health Plans (iFHP), a CEO network of the global health insurance industry based in London, in partnership with the Health Care Cost Institute (HCCI) in the United States, and iFHP member companies in eight countries, today published the latest International Comparison of Health Prices Report. The report compares the median prices…
-
Insulin Use Explains Variation in Level, but not Growth, of Out-of-Pocket Spending on Insulin Products
Read more: Insulin Use Explains Variation in Level, but not Growth, of Out-of-Pocket Spending on Insulin ProductsWe previously published two blogs discussing trends in out-of-pocket spending on insulin products. First, we presented data illustrating how average monthly out-of-pocket spending in 2017 varied considerably by month, particularly for individuals enrolled in consumer-directed health plans (CDHPs) that carry higher deductibles. Second, we examined the relationship between increasing point-of-sale prices between 2012 and 2017…
-
Rising Point-of-Sale Prices for Insulin Correspond with Higher Out-of-Pocket Spending on Insulin in January
Read more: Rising Point-of-Sale Prices for Insulin Correspond with Higher Out-of-Pocket Spending on Insulin in JanuaryEarlier this week we presented data on out-of-pocket spending on insulin during each month in 2017. In that blog, we showed that enrollees in employer-sponsored health insurance paid more out-of-pocket for insulin products at the beginning of the calendar year. We examined the relationship between increasing point-of-sale prices for insulin and higher out-of-pocket spending in…
-
Out-of-Pocket Spending on Insulin is Highest at the Beginning of the Year
Tags: Commercially Insured, Consumer-Directed Health Plans, Diabetes, Drug Spending, Geographic Variation, Insulin
Read more: Out-of-Pocket Spending on Insulin is Highest at the Beginning of the YearPeople who get health insurance through their jobs pay more than twice as much for insulin at the beginning of the year than they do at the end of the year, on average. New analysis of HCCI data shows that, nationally, in January 2017, average out-of-pocket spending on insulin was $105. This spending declined every…
-
Health Care Spending in New York Growing Faster Than Rest of U.S.
Tags: Commercially Insured, Drug Spending, Geographic Variation, Inpatient Spending, New York, Outpatient Spending, Physician Spending, Prices, Spending, Utilization
Read more: Health Care Spending in New York Growing Faster Than Rest of U.S.Spending per person in employer-sponsored plans reaches all-time high of $6,335 Health care spending for the average New Yorker with employer-sponsored health insurance is increasing faster in New York State than the rest of the country, according to a new analysis released today by the New York State Health Foundation (NYSHealth) and the Health Care…
-
The New York Times: Express Scripts Offers Diabetes Patients a $25 Cap for Monthly Insulin
Read more: The New York Times: Express Scripts Offers Diabetes Patients a $25 Cap for Monthly InsulinHCCI’s research on rising insulin list prices was recently cited by The New York Times in its reporting on Express Scripts’ new plan to offer a $25 cap for month insulin. From the article: “Consumers whose drug benefits are managed by Express Scripts could see their out-of-pocket costs for insulin limited to $25 a month…
-
2017 Annual Health Care Cost and Utilization Report Webinar
Tags: Drug Spending, HCCUR, Inpatient Spending, Outpatient Spending, Physician Spending, Prices, UtilizationRead more: 2017 Annual Health Care Cost and Utilization Report WebinarHCCI recently held a webinar to discuss the 2017 Annual Health Care Cost and Utilization Report.
-
2017 Health Care Cost and Utilization Report
Tags: Drug Spending, HCCUR, Inpatient Spending, Out-of-Pocket, Outpatient Spending, Physician Spending, Prices, Utilization
Read more: 2017 Health Care Cost and Utilization ReportThe 2017 Health Care Cost and Utilization Report shows that spending per privately insured person grew by 4.2 percent, the second year in a row of spending growth over four percent. Price increases were the primary driver. The report covers the period 2013 through 2017 and includes claims data from four national insurance companies: Aetna, Humana, Kaiser Permanente, and…
-
HCCI Insulin Report Receives Extensive Media Coverage
Tags: CBS, Chronic Conditions, CNN, Diabetes, Drug Spending, HCCI News, Insulin, NBC, Prices, The New York TimesRead more: HCCI Insulin Report Receives Extensive Media CoverageHCCI’s recent report on trends in rising insulin prices received additional media coverage in the last week in outlets including NBC, CBS, CNN, The New York Times, The Hill, U.S. News & World Report, and USA Today. From CNN: “Congress and the Trump administration continue to push for a drug pricing plan and were given more…